ACN Newswire
Read More

谭仔国际成功进军国际市场

tallulah
1 minute

HONG KONG, May 16, 2022 - (亚太商讯 via SEAPRWire.com) - 谭仔国际有限公司（「谭仔国际」或「公司」，连同其附属公司，「集团」；港交所股份代号：2217）作为专营米线的领先及知名快速休闲连锁餐厅，公布其于香港上市后首次全年业绩。尽管香港在截至2022年3月31日止年度（「2022财政年度」）的最后一季度爆发COVID-19第五波疫情，集团收益按年仍显著上升26.8%至2,275.3百万港元。撇除一次性的上市费用及COVID-19相关政府补贴，2022财政年度的年度经调整溢利上升17.8%至165.5百万港元。 摘要2022财政年度表现亮眼-- 收益按年上升26.8%至2,275.3百万港元，主要由于经营的餐厅数量增加及可比较餐厅收益上升 -- 经营利润增长38.2%至476.7百万港元 -- 经营利润率上升1.7个百分点至20.9% -- 撇除一次性的上市费用及COVID-19相关政府补贴，年度经调整溢利上升17.8%至165.5百万港元餐厅网络扩张-- 集团成功把独特、地道的「谭仔味」带到不同地区，在深圳、广州及东京的新店旋即获得热烈回响-- 截至2022年3月31日，集团在香港、中国内地、新加坡及日本共有175间餐厅，对比2021年3月31日增加28间-- 在中国内地开设了8间餐厅，于东京开设的首间分店反应热烈 -- 谭仔国际旨在进一步扩展在香港、大湾区、新加坡及日本的餐厅网络，计划在2023财政年度的第一季度分别在日本的吉祥寺和惠比寿开设另外两家餐厅随着疫情缓解，谭仔国际香港餐厅的收益在首三季度快速强势反弹至COVID-19疫情前的水平。这归因于集团保持优秀的食物质量、多元化的食物选择及卓越的服务质素，获得一群忠实顾客的支持。香港整个餐饮业在2022财政年度第四季度受到COVID-19疫情爆发的影响而陷入困境，但由于集团品牌受广泛认可、推出高价值配料、小食及新产品取得重大成功及得到忠实顾客的长期支持，因此仍能保持业务稳定。2022财政年度的收入增长主要由于经营的餐厅数目上升，以及香港的可比较餐厅收益稳步增长。与此同时，经营利润上升38.2%至476.7百万港元，而经营利润率上升1.7个百分点至20.9%。这是由于人力资源效率得以改善，使员工成本占收益的百分比下降；及餐厅业绩改善，使用权资产的折旧、租金及相关开支占比下降。集团继续录得健康的财务状况，于2022年3月31日的现金及现金等价物为1,365.2百万港元。董事会建议于2022财政年度派付末期股息每股11.4港仙，或合共约152.4百万港元 。业务回顾第五波COVID-19疫情影响下仍录得稳定的可比较餐厅收益增长作为优化菜单策略的一部分，集团在2022财政年度推出了二十多款新产品，包括配料、汤底、小吃和饮料。引入高价值配料及小食，加上成功的营销活动及于...

ACN Newswire
Read More

TJI Achieves a Successful Leap to International Market

indie
8 minutes

HONG KONG, May 16, 2022 - (ACN Newswire via SEAPRWire.com) - Tam Jai International Co. Limited ("TJI" or the "Company", and together with its subsidiaries, the "Group"; HKEX stock code: 2217), a leading and renowned mixian-specialised fast casual restaurant chain, announced its first annual results after its listing in Hong Kong. Revenue of the Group saw a notable year-on-year increase of 26.8% to HK$2,275.3 million for the year ended 31 March 2022 ("FY2022"), despite the 5th wave of COVID-19 outbreak in Hong Kong in the last quarter of FY2022. Excluding one-off listing expenses and government subsidies in relation to COVID-19, its adjusted profit for the year rose by 17.8% to HK$165.5 million in FY2022. HighlightsProminent Performance in FY2022-- Revenue increased by 26.8% to HK$2,275.3 million year-on-year, mainly attributable to the increased number of restaurants in operation and growth in comparable restaurants revenue-- Operating profit of restaurant operations increased by 38.2% to HK$476.7 million-- Operating profit margin up by 1.7 percentage points to 20.9% -- Excluding the one-off listing expenses and government subsidies in relation to COVID-19, adjusted profit for the ...

ACN Newswire
Read More

The Executive Talk: Kerry Express (Thailand) PCL (SET: KEX)

indie
6 minutes

BANGKOK, May 16, 2022 - (ACN Newswire via SEAPRWire.com) - Kerry Express (Thailand) PCL (SET: KEX) Chief Executive Officer, Mr. Alex Ng discusses the company's strategy behind its achievement as the leading express parcel delivery in the country in The Executive Talk (TET) by ShareInvestor.1. Last year, the COVID-19 pandemic massively affected the economy. How has it challenged your business, and how did you cope with it?Many people understand that Kerry must benefit from COVID-19 because more and more people shop online during the lockdown. Therefore, we have to deliver these parcels to their homes. So yes, in terms of business growth, we have experienced recorded high business growth in the past couple of years. But generally speaking, we do not like Covid-19. It disturbed our daily operations in a very big way. The supply of manpower, truck movement, and resource management planning got very difficult. Therefore, we all hope that the Covid-19 crisis will end soon.However, I must admit that we managed the crisis very well while many transportation, logistics, and express companies did not effectively plan or overprepare for the situation. You may have read on the news that some c...

ACN Newswire
Read More

CNERGENZ Berhad IPO Shares Oversubscribed by 40.32 Times

indie
3 minutes

KUALA LUMPUR, May 13, 2022 - (ACN Newswire via SEAPRWire.com) - CNERGENZ Berhad (CNERGENZ) is pleased to announce that the share allocation to the Malaysian public from its IPO has been oversubscribed by 40.32 times.Chief Executive Officer & Executive Director of CNERGENZ Berhad, Mr. Lye Yhin ChoyCNERGENZ's IPO comprises a public issue of 100,000,000 new ordinary Shares which were made available for application in the following manner:- 25,000,000 Issue Shares available for application by the Malaysian Public;- 10,000,000 Issue Shares reserved for application by the eligible directors and employees as well as persons who have contributed to the success of the CNERGENZ group (Eligible Persons);- 52,750,000 Issue Shares by way of private placement to identified institutional and/or selected investors; and- 12,250,000 Issue Shares by way of private placement to identified Bumiputera investors approved by the Ministry of International Trade and Industry, Malaysia (MITI);and an offer for sale of 50,000,000 Offer Shares by way of private placement to identified Bumiputera investors approved by the MITI.A total of 16,186 applications for 1,033,093,200 Issue Shares were received from t...

ACN Newswire
Read More

日清食品2022年首季录得稳健业绩

tallulah
1 minute

HONG KONG, May 13, 2022 - (亚太商讯 via SEAPRWire.com) - 日清食品有限公司（「日清食品」或「公司」，连同其附属公司统称「集团」股份代号：1475）今天公布截至 2022年3月31日止三个月（「报告期」）未经审核之2022年首季度财务资料。集团收入由2021年同期的964.5百万港元按年增加10.1%至1,061.8百万港元。毛利按年上升7.4%至332.8百万港元（2021年：309.9百万港元）。毛利率为31.3%（2021年：32.1%），主要由于原材料价格及其他生产成本上升所致。公司拥有人应占溢利为90.3百万港元（2021年：93.2百万港元）。集团香港业务的收入按年增加6.6%至357.9百万港元，主要受惠于袋装方便面的需求增加。中国内地业务方面，集团于报告期内采取措施以扩大销售区域及强化其「合味道」品牌，收入增加11.9%（按当地汇率：8.6%）至703.9百万港元，主要由于杯装方便面的销量上升所致。日清食品执行董事、董事长及首席执行官安藤清隆先生表示：「疫情持续，令大众的生活和经济复苏充满不确定因素。尽管营商环境充满挑战，我们仍致力确保向客户稳定地提供既优质又安全的产品，并维持盈利增长。我们将加强生产能力以及推行节约成本的措施，以继续提高生产效率。在配合公司策略的前提下，我们亦会持续强化产品组合，务求提升整体竞争力，为所有持份者缔造可持续价值。」详情请参阅公告：https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0513/2022051300231_c.pdf 有关日清食品有限公司日清食品有限公司（「集团」；股份编号：1475）为一间在中国内地及香港知名的食品公司，旗下众多品牌不仅知名度高，且广受顾客喜爱，并为香港最大的方便面公司。集团于1984年正式于香港设立营业据点。集团主要生产及销售两个核心企业品牌「日清」及「公仔」，以及多元化的家庭食品品牌组合，出品具标志性和优质的方便面、冷冻食品及其他食品。集团五个旗舰品牌「合味道」、「出前一丁」、「公仔面」、「公仔点心」及「福」在香港亦是其各自食品类别中最受欢迎的选择。中国内地市场方面，集团以创新技术推出「ECO杯」概念，销售活动主要集中在中国内地的一线及二线城市。日清食品被纳入8项恒生指数，包括恒生综合指数、恒生消费品制造及服务业指数、恒生港股通指数、恒生港股通中小型股指数、恒生港股通小型股指数、恒生港股通中国内地公司指数、恒生港股通非AH股公司指数及恒生小型股 （可投资） 指数。详情请浏览 www.nissingroup.com.hk。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire
Read More

Nissin Foods Achieves Steady 2022 Q1 Financial Results

indie
3 minutes

HONG KONG, May 13, 2022 - (ACN Newswire via SEAPRWire.com) - Nissin Foods Company Limited ("Nissin Foods" or the "Company", and together with its subsidiaries, the "Group"; Stock code: 1475) today announced its unaudited first quarter financial information for the three months ended 31 March 2022 ("the Reporting Period"). The Group's revenue increased by 10.1% year-on-year ("YoY") from HK$964.5 million to HK$1,061.8 million. Gross profit grew 7.4% YoY to HK$332.8 million (2021: HK$309.9 million). Gross profit margin was 31.3% (2021: 32.1%), mainly a result of the increased prices of raw materials and other production costs. Profit attributable to owners of the Company was HK$90.3 million (2021: HK$93.2 million). Revenue from Hong Kong operations increased by 6.6% YoY to HK$357.9 million due to a surge in demand of bag-type instant noodles. As for Mainland China operations, having taken steps to expand its geographical sales territories and strengthen its "Cup Noodles" brand in the Reporting Period, revenue increased by 11.9% (in local currency: 8.6%) to HK$703.9 million, mainly contributed by the growth in sales volume of cup-type instant noodles.Mr Kiyotaka ANDO, Executive Directo...

ACN Newswire
Read More

祝贺！国际顶级医学期刊《自然-医学》同时发表两篇关于华领医药全球首创糖尿病新药多格列艾汀的III期研究结果的同行评议论文

tallulah
1 minute

SHANGHAI, CHINA, May 13, 2022 - (亚太商讯 via SEAPRWire.com) - 华领医药(“公司”，香港联交所主板股份代号：2552.HK)今日宣布，国际顶级医学刊物《自然-医学》（Nature Medicine）杂志同时在线发表了两篇公司全球首创糖尿病新药葡萄糖激酶激活剂（GKA）多格列艾汀（dorzagliatin）的III期注册临床研究结果的同行评议论文。两篇论文分别详细展示和描述了多格列艾汀单药（SEED研究）用于治疗新诊断未用药2型糖尿病患者，以及多格列艾汀联合二甲双胍（DAWN研究）用于治疗二甲双胍足量治疗失效2型糖尿病患者的临床疗效和安全特征。葡萄糖激酶激活剂的III期临床研究成果首次发表在《自然-医学》杂志，代表中国大型注册临床研究成果开始走上国际舞台。多格列艾汀是全球首次完成2型糖尿病III期注册临床研究的GKA类原创新药，由中国研究者领导开发。两篇论文也是《自然-医学》杂志首次发表由中国研究者作为第一作者和通讯作者撰写的新机制糖尿病首创新药。两项研究均表明，在对两类2型糖尿病患者的治疗过程中，通过修复葡萄糖激酶（GK）的传感器功能缺陷，多格列艾汀能够持续、有效降低2型糖尿病（T2D）患者的糖化血红蛋白，显著降低餐后两小时血糖，在无低血糖条件下血糖达标率高，具有良好的安全性和耐受性，持续改善β细胞功能和降低胰岛素抵抗。多格列艾汀是华领医药历时10年自主研发的以GK为靶点用于治疗2型糖尿病的全球首创口服新药。GK在维持人体血糖稳态过程中发挥着核心作用，作为葡萄糖传感器感知人体血糖变化，及时刺激控糖器官分泌胰岛素、GLP-1或胰高糖素，有效调控人体血糖水平，将血糖控制在稳态范围之内（4-6.5 mmol/L的葡萄糖区间）。葡萄糖敏感性受损，主要表现为胰岛β细胞的葡萄糖刺激胰岛素分泌（GSIS）功能受损，餐后血糖升高，血糖波动增大，是T2D的源头病因。多格列艾汀作用于胰腺、肝脏、肠道等血糖调控器官的葡萄糖激酶，通过修复T2D患者的GK功能，修复人体对血糖水平变化的敏感性，改善胰岛素早相分泌和β细胞功能，降低血糖波动，重塑血糖稳态，控制和延缓2型糖尿病的进展，实现糖尿病停药缓解。华领医药已经先后发表了10多篇基础研究和临床研究结果方面的论文，不断阐明“修复传感、重塑稳态、从源头治疗糖尿病”的科学概念，《自然-医学》杂志发表的III期研究成果正是对此创新概念的临床验证。2021年3月，华领医药向国家药品监督管理局（NMPA）递交了多格列艾汀用于治疗T2D的新药上市申请，并于4月获得受理。目前，多格列艾汀处于审核冲刺阶段，华领医药正在积极配合NMPA的工作，争取尽快获得该药的新药上市批准。《自然-医学》是《自然》（Nature）旗下专注生物医学领域的学术期刊，重点关注“展示新颖疾病过程的机理，有直接证据的生理相关的...

ACN Newswire
Read More

Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine

indie
14 minutes

SHANGHAI, CHINA, May 13, 2022 - (ACN Newswire via SEAPRWire.com) - Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin, a glucokinase activator (GKA) and first-in-class investigational drug of the Company for the treatment of diabetes, were published online simultaneously by Nature Medicine, an international top medical journal. These two papers described and analyzed the clinical efficacy and safety characteristics of dorzagliatin monotherapy (SEED) in drug-naive Type 2 diabetes (T2D) patients and the combination therapy of dorzagliatin and metformin (DAWN) in patients who failed in metformin adequacy therapy for the treatment of T2D respectively.It was the first time for Nature Medicine to publish the results of Phase III trials of a GKA, representing the results of large registered clinical studies in China. Dorzagliatin is a new first-in-class GKA antidiabetic drug to successfully complete the Phase III registered clinical study in the world, which was led by Chinese researchers. The two papers are also the first to be published ...

ACN Newswire

兴业银行完成境外《可持续金融共同分类目录》绿色债券定价

tallulah
1 minute

HONG KONG, May 12, 2022 - (亚太商讯 via SEAPRWire.com) - 2022年5月11日，兴业银行香港分行在国际资本市场成功完成3年期6.5亿美元中欧《可持续金融共同分类目录》主题绿色债券的簿记和定价，发行票息3.25%，认购倍数为5.23倍，受到了各界投资者的热烈追捧。据悉，本期债券募集资金的投向和管理均在《兴业银行绿色债券框架》下进行，专项聚焦于“可再生能源”和“低碳及低排放交通”类别的优质绿色项目，符合国际资本市场协会（“ICMA”）《绿色债券原则》，在取得Sustainalytics（全球领先ESG评级及研究公司）第二方认证意见的基础上，同步聘请香港品质保证局 (“HKQAA”) 出具第二方意见，确保债券募集资金投向和管理方式严格符合《可持续金融共同分类目录》和绿色债券国际公允标准。《可持续金融共同分类目录》于2021年11月发布，该目录由中国人民银行与欧盟委员会相关部门共同牵头完成，包含了中欧双边共同认可的绿色经济活动清单。“本期绿色债券发行基于中欧《可持续金融共同分类目录-减缓气候变化》，不仅有利于加快推动碳减排，助力‘双碳’目标实现，同时也是我行积极响应中国人民银行关于推动绿色金融标准统一、完善绿色金融标准体系号召的重要实践。”兴业银行相关负责人表示。作为中国首家赤道银行，也是国内最早探索绿色金融的商业银行，兴业银行顺应“双碳”发展潮流，进一步提升绿色金融战略高度，将与碳减排相关的节能环保产业、清洁生产产业、清洁能源产业等作为绿色金融重点支持领域，并提出“十四五”期间绿色金融业务规模实现翻番的目标，持续擦亮“绿色银行”名片。截至3月末，兴业银行绿色金融融资余额1.46万亿元，较年初增长763亿元；自2018年首秀境外可持续资本市场以来，已在境外累计发行绿色债券23.16亿等值美元。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

ACN Newswire
Read More

Soluna Raises $35M from Spring Lane Capital to Build Green Data Centers for Crypto, Machine Learning

indie
4 minutes

ALBANY, NY, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Soluna Holdings, Inc. ("SHI" or the "Company"), (NASDAQ: SLNH), the parent company of Soluna Computing, Inc. ("SCI"), secured $35 million in project financing to develop green data centers co-located with renewable energy assets. Spring Lane Capital, a private equity firm, invested private funds in Soluna as a part of their strategy focused on hybrid project capital for sustainability solutions in the energy, food, water, waste and transportation industries. The capital will help develop three behind-the-meter (BTM) projects designed to convert wasted renewable energy into clean computing services such as bitcoin mining and artificial intelligence."Soluna is the only true green bitcoin company we've yet seen," said Rob Day, Spring Lane Capital Partner and Co-Founder. "Going after wasted renewable energy 'spilled power' is a compelling solution and fixes both bitcoin's climate problem and wind power's grid problem."Michael Toporek, CEO of Soluna Holdings, Inc. said, "Consistent with our previously articulated strategy, we continue to pursue opportunities that we believe enable us to optimize our cost of capital. The Sprin...

ACN Newswire

长江电力发挥清洁能源优势 开启高质量发展新篇章

tallulah
1 minute

BEIJING, CHINA, May 12, 2022 - (亚太商讯 via SEAPRWire.com) - 中国长江电力股份有限公司（以下简称“长江电力”，股票代码600900.SH）2021年度暨2022年第一季度业绩说明会在上证路演中心举办，独立董事张必贻先生、财务总监詹平原先生、董事会秘书薛宁先生等多位高管出席了业绩说明会，就公司业绩成果、战略布局、风险管理等问题与投资者、分析师进行了沟通交流。长江电力管理并运行三峡、葛洲坝、溪洛渡、向家坝、乌东德、白鹤滩等6座巨型水电站，是全球最大的水电上市公司。2021年，长江电力所属梯级电站年度累计发电量2,083.22亿千瓦时，超计划完成发电任务；拟每10股派发现金红利8.153元（含税）（人民币，下同）。其中，三峡电站年发电量第三次超千亿千瓦时，葛洲坝电站年发电量再创新高，其代管的两座电站，白鹤滩电站发电155.89亿千瓦时、乌东德电站发电389.72亿千瓦时，为迎峰度冬和电力保供贡献了可观增量。同时，长江电力公告2022年一季度业绩情况，2022年一季度，累计发电量469.6亿千瓦时，同比增长约27%。长江电力成功实现了一季度业绩“开门红”。截至目前，长江电力水电总装机容量4,559.5万千瓦，其中，国内水电装机4,549.5万千瓦，占全国水电装机的11.64%，其代管的乌东德、白鹤滩水电站装机共1,620万千瓦，占全国水电装机的4.14%。资产重组与战略投资并举 夯实全球水电巨擘龙头地位2021年11月，长江电力公告启动重大资产重组计划，拟注入乌东德电站、白鹤滩电站，截至目前相关工作正在有序推进。乌东德电站、白鹤滩电站全部注入后，长江电力可通过长江流域的六座巨型水电站实现“六库联调”，将大幅提升其水电装机量和流域梯级联合调度能力，为下游带来可观的节水增发电量，进一步巩固长江电力全球水电巨擘的龙头地位。在做强水电主业的同时，长江电力积极开展产业链上下游和相关新兴领域战略投资，2021年实现投资收益54.26亿元，创历史新高，实现公司收益有效增厚。同时，借助大水电运维核心能力，有序推进金沙江下游风光水储一体化可再生能源开发，利用水风光互补形式布局推进抽水蓄能业务的发展，创新推进智慧综合能源、城市绿色综合能源管家模式，积极布局“源网荷储”一体化发展。目前，长电新能公司已注册成立，在积极推进金沙江下游水风光一体化基地的开发和水风光互补的运行调度研究。长江电力现已获取了内蒙古固阳“源网荷储”等一批大基地项目，并锁定了甘肃张掖盘道山、重庆涪陵太和等抽水蓄能和新能源项目。审慎推进国际化拓展 向世界一流清洁能源上市公司迈进做大做强国内业务的同时，长江电力继续向国际拓展。2021年，长江电力顺利完成秘鲁路德斯公司项目强制要约收购工作，克服疫情影响向秘鲁派驻第二批现场管控团队，完成调整董事会构成，增加外籍董事等管理任...

ACN Newswire

贝壳今日香港上市：房产交易服务赛道领跑者 数字化标准化先锋

tallulah
1 minute

HONG KONG, May 12, 2022 - (亚太商讯 via SEAPRWire.com) - 随着市场需求的迅猛增长，近年，房产交易服务步入黄金期，在此背景下，贝壳控股有限公司（以下简称“贝壳”）迎来发展良机，不仅拥有出色的业绩记录，且通过线上线下双网驱动、大力发展数字化标准化、提升自主科技实力筑牢行业领先地位，继续引领行业发展。今日，贝壳以介绍方式于港交所主板双重主要上市，A类普通股正式开始在香港联交所交易，股票代码为“2423.HK”，贝壳此次上市受到投资者的积极关注。线上线下一体化平台引领行业发展 数字化、标准化提升核心竞争力根据灼识咨询报告，按2021年的总交易额计，贝壳是中国最大房产交易和服务平台，在中国居住行业中的市场份额从2019年的6.4%增至2021年的9.7%。线下看，贝壳拥有深耕社区的庞大网络，覆盖中国100多个城市逾45,000家经纪门店；线上看，贝壳通过加强数字化运营实现效率提升，线下线上无缝整合推动业务快速发展。业内预计，未来随着线上线下一体化运营能力的持续释放，贝壳有望进一步扩大市场份额。除了线下线上一体化成功运营，贝壳三大组成部分打造行业数字化、标准化先锋，进一步提升了平台核心竞争力。信息方面，贝壳实时数据库“楼盘字典”是中国最全面的住宅房产数据库，能够快速核实平台二手房房源真实性，消除虚假、重複或过期房源导致的交易效率低下。截至2021年12月31日，该平台有约430万套二手房交易的真房源，根据灼识咨询报告，在中国排名第一。交易流程方面，贝壳通过ACN网络实现数字化和标准化，ACN网络使多名经纪人能够合作完成一单交易，实现频率更高的跨门店和跨品牌合作。服务质量方面，贝壳通过向门店经理和经纪人提供SaaS系统等工具，提升门店的运营效率，夯实行业领先地位。自主科技构筑竞争壁垒 网络效应强劲打开增长空间贝壳高度重视科技、大力投资科技开发，通过使用虚拟现实、人工智能等新科技不断优化客户体验，由此构筑了竞争壁垒。其自主科技“如视VR”看房工具实现了经纪人主要工作流程的数字化和标准化，大幅提升客户决策效率，并通过引入“贝壳好房”，将人工智能用于推荐符合个人喜好的优质资讯，进一步提升推荐准确性且加快完成交易，增强了行业竞争力。科技助力下，贝壳平台拉近了与所在生态系统和行业的各个参与者的距离，并产生显著的网络效应，打开增长空间。贝壳不仅与领先的房地产商建立业务联系，新房交易收入由2020年的人民币379亿元快速增至2021年人民币465亿元，成为地产项目的强大销售渠道，且将房产交易经验用于家装等其他居住服务垂直领域，2021年，来自新兴业务及其他收入达到人民币23亿元，同比增长17.9%。市场前景方面，随着中国继续完善房地产市场长效机制并推动稳定均衡的增长，连接供需两端的房产经纪服务迎来了重要的市场机会。此外，包括家装家居等在内...

ACN Newswire
Read More

Star Teen Filipino Race Driver Bianca Bustamante Unveils NFT Project to Achieve her F1 Dream

indie
6 minutes

Launches groundbreaking project, "The Dark Horse" NFT Access Pass, to support basic living and training costsInclusive community offers fans unprecedented insight into her journey up the global racing ladderHer NFT Access Pass includes behind-the-scenes content; additional drops and airdrops; plus future prize pools plannedMANILA, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Bianca Bustamante, a 17 year-old rising motorsport star from the Philippines, announced that she is launching a groundbreaking project, The Dark Horse - an NFT Access Pass that redefines the career progression of young athletes by embracing technology, social media and community building in the age of blockchain and web3.0. The project will ultimately enable her to build long term engagement with her fan community in ways never imagined before.Bustamante recently secured a coveted race seat in W Series' Academy team, as the young Filipino driver continues to demonstrate her impressive talent ahead of her debut formula car season. Her talent is proven, being a multiple Asian champion in karting, and was the only racer selected on this year's W Series grid to come straight out of karting into Formula 3 machi...

ACN Newswire
Read More

Society Pass Inc (Nasdaq: SOPA) Reports 1Q 2022 Financial Results, Sees 4,582% Year on Year Revenue Growth and Cash on Hand Growth of 33% from year 2021

indie
5 minutes

SINGAPORE, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Society Pass Incorporated (Nasdaq: SOPA) ("SoPa" or the "Company"), Southeast Asia's leading loyalty and ecommerce ecosystem, announced that first quarter 2022 revenues grew 4,582% year on year (from $9,506 for first quarter ended 31 March 2021 to $445,090 for first quarter ended 31 March 2022). The Company also reported cash on hand grew over 33% from $23.3 million on 31 December 2021 to $31.0 million on 31 March 2022.With the closed acquisitions of the Pushkart and Handycart business units, SoPa has amassed over 1.6 million registered consumers and 5,500 registered merchants/brands onto its ever expanding ecosystem.Society Pass expects to file its 1Q 2022 Form 10-Q with the Securities and Exchange Commission later this month. During the first quarter 2022, the Company completed the corporate restructuring of its subsidiary Leflair's Vietnam operations into Leflair Group, an integrated lifestyle retail ecosystem to capture Southeast Asia's fast growing 100B+ USD retail market, as well as the integration of its recent food and beverage delivery acquisitions, Pushkart and Handycart, onto the SoPa ecosystem.Commenting on So...

ACN Newswire
Read More

Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022

indie
6 minutes

SINGAPORE, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or losses attributable to shareholders of S$7.2 million for the quarter ended 31 March 2022 (1Q2022) compared to S$5.8 million in the corresponding period (1Q2021).Dr Ng Chin Siau, Chief Executive Officer of Q&M Dental said, "We are heartened by our continuous strong performance in 1Q2022 following a record-setting year FY2021. Our core dental business will remain strong, and with the abolishing of most of the pandemic restrictions, a positive impact on the economy, we are looking forward to resuming our growth trajectory of expanding our network of clinics in the coming quarters."Growth & Expansion in OperationsAs at 31 March 2022, the Group's number of dental outlets in Singapore has grown to 99, from 85 as at 31 March 2021. Similarly in Malaysia, the number of dental outlets has increased to 41, as compared to 36 previously.The Group also continues to focus on its expansion into medical diagnostics, with its associated Company, Aoxin Q&M Dental Group Limited and through its ...

ACN Newswire
Read More

Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策

tallulah
1 minute

SYDNEY, May 12, 2022 - (亚太商讯 via SEAPRWire.com) - Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。峰会将汇集领先的 Novotech 专家的见解，这些专家利用亚太地区数十年的肿瘤临床经验。 它们包括：- Ramandeep Sharma 博士，Novotech 高级医疗监测员- Vivian Gu 博士，临床开发与监管负责人，CMO，Novotech China在这里注册： https://www.eventbrite.com/e/pre-asco-china-2-gono-go-decisions-based-on-early-phase-oncology-trials-tickets-330427145487活动日期：- 中国时间：2022年5月14日星期六上午9:00-10:30- 美国东部标准时间：2022 年 5 月 13 日星期五下午 9:00-10:30- 美国太平洋标准时间：2022 年 5 月 13 日星期五下午 6:00-7:30语言：英文，中文同声传译地点：现场ZOOM网络研讨会主持人：Brii Biosciences 首席营销官 Li Yan 博士； 美国华人抗癌协会（USCACA）常务理事峰会将首先由 Novotech 的高级医学监测员 Ramandeep Sharma 博士发表演讲，题为：早期阶段通过/不通过的方法、经验和考虑因素。随后将举行小组讨论，主要临床专家包括：- 上海东方医院李金医生- Brii Biosciences 首席营销官 Li Yan 博士； USCACA 董事总经理- Ramandeep Sharma 博士，Novotech 高级医疗监测员- Vivian Gu 博士，临床开发与监管负责人，CMO，Novotech China- 闫晓霞博士，Highthink- RemeGen 联合创始人、CEO & CSO 方建民博士- 恒瑞首席医疗官 Joseph Eid 博士- 库里南肿瘤学高级顾问兼 SAB 主席 Jon Wigginton 博士； BMS 前免疫肿瘤学早期临床开发负责人本月早些时候，Novotech 宣布收购美国 CRO 和 NCGS，作为其全球客户群的美国服务扩展计划的一部分。Novotech 在亚太地区以提供全方位服务、高质量的快速临床试验而享有盛誉，现在可以在美国为其生物技术客户提供临床服务，以支持后期的全球研究。NCGS 于 1984 年在南卡罗来纳州成立，拥有生物制药客户群。 NCGS 在美国拥有约 300 名专业人员。Novotech首席执行官 John Moll...

ACN Newswire
Read More

拥有 48 家万豪酒店品牌及其他多家酒店的知名连锁酒店开发商 Lance Shaner 向旗下酒店及领先连锁酒店推荐使用 Sky 的 Plug & Play 智能平台技术

tallulah
1 minute

MIAMI, FL, May 12, 2022 - (亚太商讯 via SEAPRWire.com) - SQL Technologies Corp.（纳斯达克股票代码：SKYX）（“Sky Technologies”或“本公司”），一家拥有高度颠覆性智能平台技术的公司，拥有超过 60 项美国和全球专利和正在申请的专利，可提高家庭的安全性和智能家居生活方式和建筑物，今天宣布著名的酒店企业家 Lance T. Shaner 将担任 Sky 新成立的酒店顾问委员会的主席。Lance T. Shaner 担任 Shaner Hotel Group 的董事长兼首席执行官。他毕业于阿尔弗雷德大学，为 Shaner 家族的公司提供商业战略和创业精神。在他的领导下，这些公司已经完成了数十亿美元的交易，并已发展成为一个备受尊敬的领先商业集团，由 60 多个万豪酒店品牌、希尔顿、洲际酒店集团、Choice 和独立品牌酒店组成，在全球拥有超过 3,500 名员工。万豪最近授予其酒店集团 2021 年“回归意向”奖，万豪认为这是他们最重要的奖项，因为它表明了消费者回归的可能性。除了他的商业成就外，兰斯还因其在社区中担任众多领导职务而获得认可，包括年度中心县企业家和 2019 年 CBICC 终身成就奖。由 Shaner 先生担任主席的酒店顾问委员会预计将协助推动智能 SkyPlug 和相关 Sky Platform 应用于住宿设施，包括酒店、度假村、不断发展的度假租赁行业和公寓楼。Shaner先生说：“我很期待加入Sky，因为我坚信公司的智能平台技术有能力让酒店瞬间变得智能和安全，每间客房只需几分钟，整个酒店只需几天。这是改变酒店、住宿和公寓建筑行业的游戏规则。我坚信公司的技术将使酒店和建筑成为智能的新标准。”Sky Technologies 的创始人兼执行主席 Rani Kohen 补充说：“我们很荣幸地欢迎 Lance 加入我们最新的顾问委员会——这对我们来说是一个重大的认可，因为它来自美国领先的酒店所有者和开发商，在各个方面都有深度和经验。我们的技术可以增强的各种建筑类型。我们期待与 Lance 密切合作，将我们的产品集成到他的酒店中，同时继续与主要连锁酒店进行高层讨论。随着我们继续建立我们的行业顾问委员会，我们相信我们有能力加速我们的商业化道路，并将即将推出的产品转化为收入和大众市场的采用。”关于 SQL 技术公司由于电力是每个家庭和建筑的标准，我们的使命是让家庭和建筑成为安全先进和智能的标准。SQL Technologies Corp.（纳斯达克股票代码：SKYX）d/b/a Sky Technologies 拥有一系列极具颠覆性的先进安全智能平台技术，拥有 60 多项美国和全球专利以及正在申请的专利。我们的技术强调高品质和易用性，同时显着提高家庭和建筑物的安全性和生活...

ACN Newswire
Read More

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

indie
4 minutes

SYDNEY, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO China Summit 2022 event titled: Go/No Go Decisions Based on Early Phase Oncology Trials ('The Summit').The Summit will feature insights from leading Novotech experts tapping decades of oncology clinical experience in the APAC region. They include:- Dr. Ramandeep Sharma, Senior Medical Monitor, Novotech- Dr. Vivian Gu, Head of Clinical Development & Regulatory, CMO, Novotech ChinaRegister here: https://www.eventbrite.com/e/pre-asco-china-2-gono-go-decisions-based-on-early-phase-oncology-trials-tickets-330427145487Event Date:- China Time: 9:00-10:30 AM, Saturday, May 14, 2022- US EST Time: 9:00-10:30 PM, Friday, May 13, 2022- US PST Time: 6:00-7:30 PM, Friday, May 13, 2022Language: English, with Chinese simultaneous translationVenue: Live Zoom WebinarModerator:- Dr. Li Yan, CMO, Brii Biosciences; Managing Director, United States Chinese Anti-Cancer Association (USCACA)The Summit will start with a presentation by Novotech's Senior Medical Monitor Dr. Ramandeep Sharma titled: Ap...

ACN Newswire
Read More

Renowned Hotel-Chain Developer Lance Shaner, Owner of 48 Marriott Hotel Brands and Various Other Hotels, Recommends the Use of Sky’s Plug & Play Smart Platform Technology in His Hotels as Well as to a Leading Hotel Chain

indie
5 minutes

MIAMI, FL, May 11, 2022 - (ACN Newswire via SEAPRWire.com) - SQL Technologies Corp. (NASDAQ:SKYX) ("Sky Technologies" or "the Company"), a Company significantly enhancing safety in homes and buildings as well as smart home lifestyle, with highly disruptive smart platform technologies and over 60 issued and pending patents globally, today announced that renowned hotel entrepreneur Lance T. Shaner will Chair Sky's newly formed Hotel Advisory Board.Lance T. Shaner serves as Chairman and Chief Executive Officer of Shaner Hotel Group. A graduate of Alfred University, he provides the business strategy and entrepreneurial spirit for the Shaner family of companies. Under his leadership, the companies have completed several billion dollars in transactions and have grown into a highly respected leading business group comprised of over 60 Marriott hotel brands, Hilton, IHG, Choice and independent brand hotels with over 3,500 employees globally. Marriott recently awarded his hotel group with the 2021 "Intention to Return" Award, considered by Marriott to be their most significant award, as it indicates consumer probability to return.In addition to his business achievements, Lance has been reco...

ACN Newswire
Read More

科轩动力获选为政府可持续公共交通先导试验计划电动公共小巴供应商

tallulah
1 minute

HONG KONG, May 11, 2022 - (亚太商讯 via SEAPRWire.com) - 新能源汽车及技术综合解决方案供应商科轩动力（控股）有限公司（「公司」；股份代号：476，连同其附属公司，统称「科轩动力」或「集团」）获香港特别行政区政府选为经预审合资格供应商，为香港环保署将于2023年推行的可持续公共交通先导试验计划提供电动公共小巴。选定的APEX-MINI车型不但展示集团卓越的技术和产品优势，亦协助推广本港的环保公共交通及科轩动力的产品进入其他市场。科轩动力的APEX-MINI采用高效能钛酸锂电池，每次充电只需15分钟，便能走45公里。APEX-MINI 7米19座快充式纯电动公共小巴采用高性能钛酸锂(LTO) 电池，充电系统使用符合欧盟相关标准的车顶受电弓界面OppCharge，配合政府公共交通交汇站设置的OppCharger智能充电弓，充电15分钟便可行驶45公里，而且地台超低，方便长者和残疾人士乘搭。待运输署发出车辆类型评定及获独立评核人验证，完成相关程序后，集团将积极配合该试验计划营运APEX-MINI，并成立售后服务中心，提供保养及维修服务。科轩动力行政总裁Miguel Valldecabres Polop表示, 「我们很高兴将我们的 APEX-MINI 引入公共交通平台。该车型行驶顺畅、安全性高、且零排放，有助减少路边空气和噪音污染。而我们精干的服务团队可以时刻确保APEX-MINI等科轩动力产品在香港运作可靠高效。我们有信心我们的电动小巴获得社会充份认可，潜在应用广泛。凭借卓越的技术优势和产品质量，我们将继续为各个市场提供清洁、静音、节能的公共交通工具，实现汽车电动化。」关于科轩动力（控股）有限公司（股份代号：476）科轩动力（控股）有限公司为新能源商用车的先行者和实践者、专用客车和新能源客车整车生产商，在新能源平台化电系统及关键零部件方面有着坚实的技术基础，是出行与物流综合解决方案的供应商。集团在重庆设有生产基地，拥有广泛的海内外销售网络，及重点开拓东南亚、欧洲和拉丁美洲的高增长市场。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)